Exhibit 4.1
AMENDED AND RESTATED WARRANT AGREEMENT
This Amended and Restated Warrant Agreement (this “Agreement”) made as of January 3, 2023 is by and between Alvarium Tiedemann Holdings, Inc., a Delaware corporation, with offices at 520 Madison Ave., 21st Floor, New York, NY 10022 (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, with offices at 1 State St., 30th Floor, New York, New York 10004 (the “Warrant Agent”).
WHEREAS, the Company (then known as Cartesian Growth Corporation, a Cayman Islands exempted company (“Cartesian”)) previously entered into the Warrant Agreement, dated February 23, 2021 (the “Original Agreement”), with the Warrant Agent; and
WHEREAS, pursuant to the Amended and Restated Business Combination Agreement, dated as of October 25, 2022 (the “Business Combination Agreement”), by and among Cartesian, Rook MS LLC, a Delaware limited liability company, Tiedemann Wealth Management Holdings, LLC, a Delaware limited liability company, TIG Trinity GP, LLC, a Delaware limited liability company, TIG Trinity Management, LLC, a Delaware limited liability company, Alvarium Investments Limited, an English private limited company, and Alvarium Tiedemann Capital LLC, a Delaware limited liability company, the parties thereto consummated a business combination (the “Business Combination”), which included the domestication of Cartesian in Delaware as “Alvarium Tiedemann Holdings, Inc.” (the “Domestication”), in accordance with the terms and conditions of the Business Combination Agreement and applicable law; and
WHEREAS, as of immediately prior to the Domestication, Cartesian had outstanding: (i) certain redeemable warrants (the “Public Warrants”) to purchase Class A ordinary shares, par value $0.0001 per share, of Cartesian (the “Class A Ordinary Shares”) that were registered pursuant to Cartesian’s initial public offering registration statement and offered by Cartesian in its initial public offering of units of Cartesian’s equity securities (the “Units”), each such Unit comprised of one Class A Ordinary Share and one-third of a Public Warrant, and (ii) 8,900,000 warrants to purchase Class A Ordinary Shares that were issued in a private placement concurrently with Cartesian’s initial public offering (the “Private Placement Warrants” and, together with the Public Warrants, the “Warrants”); and
WHEREAS, the Private Placement Warrants and the Public Warrants automatically converted by operation of law into warrants to acquire shares of Class A common stock of the Company, and as a result of such conversion, the Private Placement Warrants bear the legend set forth in Exhibit B hereto; and
WHEREAS, at a moment in time after the effectiveness of the Domestication and before the closing of the Business Combination, each outstanding Unit separated into its component common stock and warrant; and
WHEREAS, each whole Warrant entitles the holder thereof to purchase one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Share”), for $11.50 per share, subject to adjustment as described herein, with only whole Warrants being exercisable and holders of the Public Warrants not being able to exercise any fraction of a Warrant; and
WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-4 (File No. 333-262644) and a proxy statement/prospectus (as amended from time to time, the “Registration Statement”) for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), of the Warrants and the Class A Shares issuable upon exercise of the Warrants; and
WHEREAS, in connection with the Business Combination, the Company and the Warrant Agent desire to amend and restate the Original Agreement; and
WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants; and
WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and
1